You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 12, March 22/29, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Research Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Men's Health, Other
 •Women's Health, Other
 •Cardiovascular Disease/ Myocardial Infarction
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic

Maternal X Chromosome, Visceral Adiposity, and Lipid Profile

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Men typically have more visceral fat and atherogenic plasma lipids than women,1 contributing to an increased risk of ischemic heart disease. This pattern has been attributed to sex steroids, but other factors may be important. A disparity in X chromosome gene expression may influence sex-specific differences in lipid metabolism and coronary artery disease.2

Genomic imprinting involves the selective expression of certain genes determined by their parental origin, often associated with DNA methylation of imprinted, or silenced, alleles.3 Genomic imprinting of X-linked genes could result in different gene expression in males and females, since females are normally mosaic for maternally and paternally inherited active X chromosomes (XM and XP), while men are monosomic for XM. Genes imprinted (silenced) on XM would still be expressed in females from cells in which the XP is active, but not expressed at all in males. Evidence for the imprinting of . . . [Full Text of this Article]

Methods

Phillip L. Van, MS; Vladimir K. Bakalov, MD
Developmental Endocrinology Branch
National Institute of Child Health and Human Development
National Institutes of Health
Bethesda, Md

Andrew R. Zinn, MD, PhD
McDermott Center for Human Growth and Development
University of Texas Southwestern Medical School
Dallas

Carolyn A. Bondy, MD
bondyc@mail.nih.gov
National Institute of Child Health and Human Development
National Institutes of Health
Bethesda



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reduced Abdominal Adiposity and Improved Glucose Tolerance in Growth Hormone-Treated Girls with Turner Syndrome
Wooten et al.
J. Clin. Endocrinol. Metab. 2008;93:2109-2114.
ABSTRACT | FULL TEXT  

Clinical Significance of the Parental Origin of the X Chromosome in Turner Syndrome
Sagi et al.
J. Clin. Endocrinol. Metab. 2007;92:846-852.
ABSTRACT | FULL TEXT  

Prolonged Rate-Corrected QT Interval and Other Electrocardiogram Abnormalities in Girls With Turner Syndrome
Bondy et al.
Pediatrics 2006;118:e1220-e1225.
ABSTRACT | FULL TEXT  

Women's Health--Advances in Knowledge and Understanding
DeAngelis and Glass
JAMA 2006;295:1448-1450.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.